SELENOS knockdown suppressed glioma proliferation, invasion, and tumor growth, reduced macrophage recruitment, decreased CSF1 expression, and promoted macrophage polarization toward a pro-inflammatory phenotype.<h4>Conclusions</h4>These findings define a selenoprotein-driven malignant glioma state associated with immune evasion and therapeutic vulnerability. The gene discussed is SELENOS; the disease is glioma.